Literature DB >> 20888923

A comparison of MR based segmentation methods for measuring brain atrophy progression.

Jeroen de Bresser1, Marileen P Portegies, Alexander Leemans, Geert Jan Biessels, L Jaap Kappelle, Max A Viergever.   

Abstract

Automated brain segmentation methods with a good precision and accuracy are required to detect subtle changes in brain volumes over time in clinical applications. However, the ability of established methods such as SIENA, US and kNN to estimate brain volume change have not been compared on the same data, nor been evaluated with ground-truth manual segmentations. We compared measurements of brain volume change between SIENA, US and kNN in terms of precision (repeatability) and accuracy (ground-truth) using one baseline and two repeated follow-up 1.5 T MRI scans after 4 years of 10 subjects. The coefficient of repeatability (brain volume/volume change) was larger for US (29.6 cc/2.84%) than for kNN (4.9 cc/0.31%) and SIENA (-/0.92%). In terms of absolute brain volume measurements US and kNN showed good correlation with the manual segmentations and with each other (all Spearman's correlation coefficients ρ≥0.96; all p<0.001). Concerning brain volume changes, SIENA showed a good (ρ=0.82; p=0.004), kNN a moderate (ρ=0.60; p=0.067) and US a weak (ρ=0.50; p=0.138) correlation with the manual segmentations. For measurements of volume change, SIENA-US (mean correlation coefficient and p-value: ρ=0.28; p=0.442) and US-kNN (ρ=0.17; p=0.641) showed a weak correlation, but correlation was fairly good for kNN-SIENA (ρ=0.65; p=0.048). In conclusion, US and kNN showed a good precision, accuracy and comparability for brain volume measurements. For measurements of volume change, SIENA showed the best performance. kNN is a good alternative if volume change measurements of other brain structures are required.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20888923     DOI: 10.1016/j.neuroimage.2010.09.060

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  28 in total

Review 1.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

2.  An open source multivariate framework for n-tissue segmentation with evaluation on public data.

Authors:  Brian B Avants; Nicholas J Tustison; Jue Wu; Philip A Cook; James C Gee
Journal:  Neuroinformatics       Date:  2011-12

3.  Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Authors:  Mohamed Ahmed; Dara M Cannon; Cathy Scanlon; Laurena Holleran; Heike Schmidt; John McFarland; Camilla Langan; Peter McCarthy; Gareth J Barker; Brian Hallahan; Colm McDonald
Journal:  Neuropsychopharmacology       Date:  2015-04-01       Impact factor: 7.853

Review 4.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

Review 5.  Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.

Authors:  François De Guio; Eric Jouvent; Geert Jan Biessels; Sandra E Black; Carol Brayne; Christopher Chen; Charlotte Cordonnier; Frank-Eric De Leeuw; Martin Dichgans; Fergus Doubal; Marco Duering; Carole Dufouil; Emrah Duzel; Franz Fazekas; Vladimir Hachinski; M Arfan Ikram; Jennifer Linn; Paul M Matthews; Bernard Mazoyer; Vincent Mok; Bo Norrving; John T O'Brien; Leonardo Pantoni; Stefan Ropele; Perminder Sachdev; Reinhold Schmidt; Sudha Seshadri; Eric E Smith; Luciano A Sposato; Blossom Stephan; Richard H Swartz; Christophe Tzourio; Mark van Buchem; Aad van der Lugt; Robert van Oostenbrugge; Meike W Vernooij; Anand Viswanathan; David Werring; Frank Wollenweber; Joanna M Wardlaw; Hugues Chabriat
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-11       Impact factor: 6.200

6.  Quantification of structural cerebral abnormalities on MRI 18 months after aneurysmal subarachnoid hemorrhage in patients who received endovascular treatment.

Authors:  Jeroen de Bresser; Joanna D Schaafsma; Merel J A Luitse; Max A Viergever; Gabriel J E Rinkel; Geert Jan Biessels
Journal:  Neuroradiology       Date:  2014-12-06       Impact factor: 2.804

7.  Impact of Markov Random Field optimizer on MRI-based tissue segmentation in the aging brain.

Authors:  Christopher G Schwarz; Alex Tsui; Evan Fletcher; Baljeet Singh; Charles DeCarli; Owen Carmichael
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2011

8.  Qualitative and quantitative analysis of MR imaging findings in patients with middle cerebral artery stroke implanted with mesenchymal stem cells.

Authors:  C P Wanamaker; S Fakhran; L M Alhilali
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-05       Impact factor: 3.825

9.  Validation of the automated method VIENA: an accurate, precise, and robust measure of ventricular enlargement.

Authors:  Hugo Vrenken; Eline K Vos; W M van der Flier; Ingrid C Sluimer; Keith S Cover; Dirk L Knol; Frederik Barkhof
Journal:  Hum Brain Mapp       Date:  2013-01-30       Impact factor: 5.038

10.  Automated measurement of the human corpus callosum using MRI.

Authors:  Timothy J Herron; Xiaojian Kang; David L Woods
Journal:  Front Neuroinform       Date:  2012-09-12       Impact factor: 4.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.